Orion Biotech Opportunities Corp. Units
ORIAU
ORIAU was delisted on the 25th of April, 2023.
14 hedge funds and large institutions have $33.2M invested in Orion Biotech Opportunities Corp. Units in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less funds holding
Funds holding: 18 → 14 (-4)
41% less capital invested
Capital invested by funds: $56.2M → $33.2M (-$23.1M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$9.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$6.93M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$4.95M |
| 3 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
-$4.93M |
| 4 |
CF
Cantor Fitzgerald
New York
|
-$2.86M |
| 5 |
GCL
Glazer Capital LLC
New York
|
-$2.05M |
ORIAU Hedge Fund Activity: Q1 2022 in Review
14 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Units (ORIAU) for Q1 2022, worth a combined $33.2M — down 41% from $56.2M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ORIAU and 1 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 0 added.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $9.81K. The largest seller was Linden Advisors, exiting entirely with an estimated $6.93M sold.
- 14 institutional investors held Orion Biotech Opportunities Corp. Units (ORIAU) as of Q1 2022, down from 18 in Q4 2021.
- Funds reported $33.2M of Orion Biotech Opportunities Corp. Units stock for Q1 2022, down 41% quarter-over-quarter.
- 1 fund opened new Orion Biotech Opportunities Corp. Units positions in Q1 2022 and 5 closed out, a net change of -4 holders.
- The largest Orion Biotech Opportunities Corp. Units buyer in Q1 2022 was Wolverine Asset Management, an estimated $9.81K added.
- The largest Orion Biotech Opportunities Corp. Units seller in Q1 2022 was Linden Advisors, an estimated $6.93M sold.
Based on aggregated 13F filings for Q1 2022.